跳至主要内容
临床试验/NCT04556864
NCT04556864Unknown不适用

Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to SARS-CoV-2 Infection

Juan Victor Lorente5 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
67
试验地点
5
主要终点
Total amount of hypotension

研究概览

简要总结

The aim of the present work is to describe the hemodynamic effects shown in patients with ARDS secondary to SARS-CoV-2 infection

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 years old.
  • Patients that are classified as a "confirmed case" according to criteria established by the Spanish Ministry of Health in its Technical Document updated on March 31,
  • This defines a "confirmed case" as a case that meets laboratory criteria (Positive PCR test for any of the SARS-CoV-2 genes).
  • Patients admitted to ICU.
  • Presence of Kirby index (PaFi) less than or equal to 300 mm Hg, with PEEP or CPAP greater than or equal to 5 cmH2O.
  • Need for radial artery cannulation for hemodynamic monitoring and/or repeated monitoring of blood gases at the discretion of the responsible physician.
  • Patients who agree (or a representative of the patient if sedated) to participate in study and who provide written informed consent.

排除标准

  • Patients being treated with veno-venous or veno-arterial ECMO
  • Patient with therapeutic restrictions due to life support
  • Patient who presents a complication that requires surgical intervention.

结局指标

主要结局

Total amount of hypotension

时间窗: 5 days

Hypotension will be defined as a hemodynamic event that occurs when the MAP falls below 65 mmHg for a minimum duration of 1 minute (3 consecutive recordings of 1 minute or more between two consecutive falls of the MAP).

次要结局

  • Acute kidney injury(Daily during 5 days)
  • Daily diuresis, daily water balance, accumulated water balance since ICU admission, daily parenteral nutrition volume, and daily enteral nutrition volume.(Daily during 5 days)
  • Atrial fibrillation(5 days)
  • Need for Hemadsorption(5 days)
  • Specific treatment for SARS-CoV2 (presence of tocilizumab, antimalarial drugs, antivirals)(5 days)
  • Continuous renal replacement therapies(5 days)
  • Corticoid treatment.(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor (Stroke volume)(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor (Stroke volume variation)(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor (Cardiac index)(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor ( HPI)(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor (Eadyn)(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor (dp/dt max,)(5 days)
  • Presence of treatment with noradrenaline; presence of treatment with dobutamine, presence of treatment with other vasoactive/ionotropic/hypotensive drugs(5 days)
  • Furosemide treatment(Daily during 5 days)

研究者

发起方
Juan Victor Lorente
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Juan Victor Lorente

Medical Doctor

Andalusian Network for Design and Translation of Advanced Therapies

研究点 (5)

Loading locations...

相似试验

Hemodynamic Impact on Critical Care Patients With... | 临床试验